Fractyl Health, Inc. Common Stock
Market Cap
130M
Short interest (May 15)
2.0%
Net Short (Jun 03 ): -0.1%
Borrow Fee
1.24%
↓ 1.4%
Available Shares
10M
↓ 0.0%
Price Chart
Company Overview
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.